Emerging Insights on the Role of Monoclonal Antibodies in Patients With COVID-19

Download All
Learn the data on the safety and efficacy of monoclonal antibodies for treatment of COVID-19 and special considerations and best practices informing their use. Read the companion ClinicalThought commentary derived from the dynamic postwebinar question and answer sessions.
Arun Mattappallil, PharmD
Jessica K. Ortwine, PharmD, BCIDP

ClinicalThought

Expert faculty answer the most compelling questions from the live ProCE symposium titled “Emerging Insights on the Role of Monoclonal Antibodies in Patients With COVID-19.”

Arun Mattappallil, PharmD Jessica K. Ortwine, PharmD, BCIDP Released: December 8, 2021
Provided by ProCE, LLC, a Clinical Education Alliance Company

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Coproduced by ProCE and the NASP Center for Specialty Pharmacy Education (CSPE).
This activity is supported by an educational grant from
GlaxoSmithKline

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings